Diagnosis of ductal carcinoma in situ (DCIS) and intraductal papilloma using fluorescence in situ hybridization (FISH) analysis

Breast Cancer

Volumn 7, Issue 4, 2000, Pages 332-336

  Komoike, Yoshifumi ^a   Motomura, Kazuyoshi ^a   Inaji, Hideo ^a   Koyama, Hiroki ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

Ductal carcinoma in situ (DCIS); Fluorescence in situ hybridization (FISH); Intraductal papilloma (IDP)

Indexed keywords

ARTICLE; BREAST TUMOR; CARCINOMA IN SITU; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; HUMAN; MONOSOMY; PAGET NIPPLE DISEASE; PAPILLOMA; PATHOLOGY;

BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MONOSOMY; PAPILLOMA;

EID: 0034566344     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/BF02966400     Document Type: Review

References (14)

1. Gebhart E, Bruderlein S, Augustus M, et al: Cytogenetic studies on human breast carcinomas. Breast Cancer Res Treat 8:125-138, 1986. (Pubitemid 17011491)
2. Pandis N, Jin Y, Gorunova L, et al: Chromosome analysis of 97 primary breast carcinomas: identification of eight karyotypic subgroups. Genes Chromosom Cancer 12:173-185, 1995.
3. Persons DL, Robinson RA, Hsu PH, et al: Chromosomespecific aneusomy in carcinoma of the breast. Clni Cancer Res 2:883-888, 1996.
4. Fiegl M, Kaufmann H, Zojer N, et al: Malignant cell detection by fluorescence in situ hybridization (FISH) in effusions from patients with carcinom. Hum Pathol 31:448-455, 2000. (Pubitemid 30262867)
5. Tsuda H, Takarabe T, Susumu N, et al: Detection of numerical and structural Alterations and fusion of chromosomes 16 and 1 in low-grade papillary breast carcinoma by fluorescence in situ hybridization. Am J Pathol 151:1027-1034, 1997. (Pubitemid 27424312)
6. Kokalj-Vokac N, Alemedia A, Gerbault-Seureau M, et al: Two-color FISH characterization of i (lq), and der (1;16) in human breast cancer cells. Genes Chromosom Cancer 7:8-14, 1993. (Pubitemid 23141735)
7. Anderson TI, Gaustad A, Ottestad L, et al: Genetic alterations of the tumor suppressor gene regions 3p, llp, 13q, 17p, and 17q in human breast carcinomas. Genes Chromosom Cancer 4:113-121, 1992.
8. Bieche I, Champeme MH, Mtifas F, et al: Two distinct regions involved lp deletion in human primary breast cancer. Cancer Res 53:4486-4488, 1993.
9. Walker RA, Dearing SJ, Lane DR, et al: Expression of p53 protein in infiltrating and in-situ breast carcinoma. J Pathol 165:203-211, 1991.
10. Nassiri M, Nadji M, Fresno M, et al: Bcl-2 is expressed minly in estrogen receptor-positive, p53-negafive breast cancer. Proc Am Assoc Canc Res 36:622, 1995.
11. Ichikawa D, Hashimoto N, Hoshima M, et al: Analysis of numerical aberrations in specific chromosomes by fluorescent in situ hybridization as a diagnostic tool in breast cancer. Cancer 77:2064-2069, 1996. (Pubitemid 26142050)
12. Kline T, Joshi L, Neal H: Fine needle aspiration of the breast: diagnosis and piffaals. Cancer 44:1458-1464, 1979.
13. Mendelin J, Grayson M, Wallis T, et al: Analysis of chromosome aneuploidy in breast carcinoma progression by using fluorescence in situ hybridization. Lab Invest 79:387-393, 1999. (Pubitemid 29190428)
14. Marinho AF, Botelho M, SchmittnFC: Evaluation of numerical abnormalities of chromosomes 1 and 17 in proliferative epithelial breast lesions using fluorescence in situ hybridization. Pathol Res Pract 196:227-233, 2000. (Pubitemid 30210274)